How is interferon gamma-1b thought to enhance immune activity in chronic granulomatous disease?

Interferon gamma-1b’s mechanism in chronic granulomatous disease remains unknown, but it is presumed to enhance macrophage killing through respiratory-burst production of toxic oxygen metabolites, while increasing macrophage HLA-DR and Fc receptor expression to augment antibody-dependent cell-mediated cytotoxicity.